SHALLCROSS STEVEN A 4
4 · Theriva Biologics, Inc. · Filed May 1, 2025
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Award
Stock Options (right to buy)
2025-04-29+190,000→ 190,000 totalExercise: $1.41From: 2025-05-01Exp: 2032-04-29→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]These stock options vest pro rata on a monthly basis over 36 months.